Replies to post #317846 on Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

It will be Cytodyn's Leronlimab and not any RdPp drug like Remde. Leronlimab is trending to be a potential SoC for COVID-19, and it should once the data comes out.

Remde is ineffective when it came addressing severe and critically ill patients; and due to the specificity of Bril's MOA, Bril could be as good or better than Leronlimab. I am excited to see our Phase II trials get going.

Timing is of the essence so I hope everything is lined up and ahead of schedule. We are a bit slow on the execution part, but now that we have $36M of cash, I hope we get moving FAST!!

[PlentyParanoid]

Funny. I wondered the same thing about Polymedix's data. It may have been that they intended to publish, but financial woes preempted that effort. Just a guess, but sad development, if true. A nice paper in well respected journal... one wonders what could have been.